Effects of Lianhuaqingwen Capsules in adults with mild-to-moderate coronavirus disease 2019: an international, multicenter, double-blind, randomized controlled trial

被引：0

作者：

Jin-ping Zheng

Yun Ling

Liang-shuang Jiang

Piroon Mootsikapun

Hong-zhou Lu

Methee Chayakulkeeree

Li-xiu Zhang

Pureepat Arttawejkul

Feng-yu Hu

Thi Ngoc Lan Truong

Roxan A. Perez

Xing Gu

Hui-min Sun

Jian-jie Jiang

Ren-jie Liu

Zhen Ding

Yang-qing Zhan

Zi-feng Yang

Wei-jie Guan

Nan-shan Zhong

机构：

[1] Guangzhou Institute for Respiratory Health,State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease

[2] The First Affiliated Hospital of Guangzhou Medical University,undefined

[3] Shanghai Public Health Clinical Center,undefined

[4] Public Health Clinical Center of Chengdu,undefined

[5] Srinagarind Hospital,undefined

[6] The Third People’s Hospital of Shenzhen,undefined

[7] Siriraj Hospital,undefined

[8] The Affiliated Hospital of Changchun University of TCM,undefined

[9] Burapha University Hospital,undefined

[10] Guangzhou Eighth People’s Hospital,undefined

[11] Guangzhou Medical University,undefined

[12] Traditional Medicine Institute of Ho Chi Minh City,undefined

[13] Dr. Jose N. Rodriguez Memorial Hospital and Sanitarium,undefined

[14] Xi’an Chest Hospital,undefined

[15] Tangshan Hospital of Traditional Chinese Medicine,undefined

[16] Kunming Third People’s Hospital,undefined

[17] First People’s Hospital of Zhengzhou City,undefined

[18] Hefei Binhu Hospital,undefined

来源：

Virology Journal | / 20卷

关键词：

Coronavirus disease 2019; Omicron; Lianhuaqingwen Capsule; Symptom resolution; Inflammation;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

共 50 条

[1] Effects of Lianhuaqingwen Capsules in adults with mild-to-moderate coronavirus disease 2019: an international, multicenter, double-blind, randomized controlled trial
Zheng, Jin-ping
Ling, Yun
Jiang, Liang-shuang
Mootsikapun, Piroon
Lu, Hong-zhou
Chayakulkeeree, Methee
Zhang, Li-xiu
Arttawejkul, Pureepat
Hu, Feng-yu
Truong, Thi Ngoc Lan
Perez, Roxan A.
Gu, Xing
Sun, Hui-min
Jiang, Jian-jie
Liu, Ren-jie
Ding, Zhen
Zhan, Yang-qing
Yang, Zi-feng
Guan, Wei-jie
Zhong, Nan-shan
VIROLOGY JOURNAL, 2023, 20 (01)
[2] Hydroxychloroquine in mild-to-moderate coronavirus disease 2019: a placebo-controlled double blind trial
Dubee, Vincent
Roy, Pierre-Marie
Vielle, Bruno
Parot-Schinkel, Elsa
Blanchet, Odile
Darsonval, Astrid
Lefeuvre, Caroline
Abbara, Chadi
Boucher, Sophie
Devaud, Edouard
Robineau, Olivier
Rispal, Patrick
Guimard, Thomas
d'Anglejean, Emma
Diamantis, Sylvain
Custaud, Marc-Antoine
Pellier, Isabelle
Mercat, Alain
CLINICAL MICROBIOLOGY AND INFECTION, 2021, 27 (08) : 1124 - 1130
[3] A 22-week, multicenter, randomized, double-blind controlled trial of Crocus sativus in the treatment of mild-to-moderate Alzheimer's disease
Akhondzadeh, Shahin
Sabet, Mehdi Shafiee
Harirchian, Mohammad Hossein
Togha, Mansoreh
Cheraghmakani, Hamed
Razeghi, Soodeh
Hejazi, Seyyed Shamssedin
Yousefi, Mohammad Hossein
Alimardani, Roozbeh
Jamshidi, Amirhossein
Rezazadeh, Shams-Ali
Yousefi, Aboulghasem
Zare, Farhad
Moradi, Atbin
Vossoughi, Ardalan
PSYCHOPHARMACOLOGY, 2010, 207 (04) : 637 - 643
[4] A 22-week, multicenter, randomized, double-blind controlled trial of Crocus sativus in the treatment of mild-to-moderate Alzheimer’s disease
Shahin Akhondzadeh
Mehdi Shafiee Sabet
Mohammad Hossein Harirchian
Mansoreh Togha
Hamed Cheraghmakani
Soodeh Razeghi
Seyyed Shamssedin Hejazi
Mohammad Hossein Yousefi
Roozbeh Alimardani
Amirhossein Jamshidi
Shams-Ali Rezazadeh
Aboulghasem Yousefi
Farhad Zare
Atbin Moradi
Ardalan Vossoughi
Psychopharmacology, 2010, 207 : 637 - 643
[5] Efficacy and safety of Lianhuaqingwen capsules, a repurposed Chinese herb, in patients with coronavirus disease 2019: A multicenter, prospective, randomized controlled trial
Hu, Ke
Guan, Wei-jie
Bi, Ying
Zhang, Wei
Li, Lanjuan
Zhang, Boli
Liu, Qingquan
Song, Yuanlin
Li, Xingwang
Duan, Zhongping
Zheng, Qingshan
Yang, Zifeng
Liang, Jingyi
Han, Mingfeng
Ruan, Lianguo
Wu, Chaomin
Zhang, Yunting
Jia, Zhen-hua
Zhong, Nan-shan
PHYTOMEDICINE, 2021, 85
[6] Dehydroepiandrosterone treatment of women with mild-to-moderate systemic lupus erythematosus - A multicenter randomized, double-blind, placebo-controlled trial
Chang, DM
Lan, JL
Lin, HY
Luo, SF
ARTHRITIS AND RHEUMATISM, 2002, 46 (11): : 2924 - 2927
[7] Therapeutic effects of minocycline on mild-to-moderate depression in HIV patients: a double-blind, placebo-controlled, randomized trial
Emadi-Kouchak, Hamid
Mohammadinejad, Payam
Asadollahi-Amin, Ali
Rasoulinejad, Mehrnaz
Zeinoddini, Atefeh
Yalda, Alireza
Akhondzadeh, Shahin
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2016, 31 (01) : 20 - 26
[8] Oral Taodan granules for mild-to-moderate psoriasis vulgaris: protocol for a randomized, double-blind, multicenter clinical trial
Ru, Yi
Yan, Xiao-Ning
Yang, Su-Qing
Gong, Li-Ping
Li, Ling-E
Chen, Jie
Zhao, Yi-Ding
An, Yue-Peng
Huang, Gang
Zhang, Jin-Fang
Yin, Qing-Feng
Wang, Rui-Ping
Li, Xin
Li, Bin
ANNALS OF TRANSLATIONAL MEDICINE, 2019, 7 (18)
[9] Efficacy and Safety of Regdanvimab (CT-P59): A Phase 2/3 Randomized, Double-Blind, Placebo-Controlled Trial in Outpatients With Mild-to-Moderate Coronavirus Disease 2019
Streinu-Cercel, Anca
Sandulescu, Oana
Preotescu, Liliana-Lucia
Kim, Jin Yong
Kim, Yeon-Sook
Cheon, Shinhye
Jang, Young Rock
Lee, Sang Joon
Kim, Sung Hyun
Chang, Ilsung
Suh, Jee Hye
Lee, Seul Gi
Kim, Mi Rim
Chung, Da Rae
Kim, Han Na
Streinu-Cercel, Adrian
Eom, Joong Sik
OPEN FORUM INFECTIOUS DISEASES, 2022, 9 (04):
[10] Efficacy and safety of Lianhuaqingwen for mild or moderate coronavirus disease 2019 A meta-analysis of randomized controlled trials
Fan, Zheng
Guo, Guiming
Che, Xiaoping
Yang, Ying
Liu, Yang
Li, Luyang
Chang, Xinyu
Han, Lijuan
Cai, Xiaorong
Tang, Huilin
MEDICINE, 2021, 100 (21) : E26059

← 1 2 3 4 5 →